This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/524982-india-abandons-local-covid-vaccine-trials/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| India seeks to fast-track Covid vaccine imports as it struggles to secure supplies for domestic production | India seeks to fast-track Covid vaccine imports as it struggles to secure supplies for domestic production |
| (4 months later) | |
| The Indian government has suspended its local “trial requirement” for “well-established” Covid vaccines, focusing on fast-tracking imports from other states, as it struggles to secure supplies to bolster domestic production. | The Indian government has suspended its local “trial requirement” for “well-established” Covid vaccines, focusing on fast-tracking imports from other states, as it struggles to secure supplies to bolster domestic production. |
| In a statement announcing the move on Thursday, New Delhi said that its approval process for Covid-19 jabs had been “amended to waive the trial requirement altogether for the well-established vaccines manufactured in other countries.” | In a statement announcing the move on Thursday, New Delhi said that its approval process for Covid-19 jabs had been “amended to waive the trial requirement altogether for the well-established vaccines manufactured in other countries.” |
| The move was linked with an announcement from India that it is in talks with Pfizer to arrange imports of doses of the company’s Covid vaccine at the “earliest possible” opportunity. Other discussions are currently ongoing with Johnson & Johnson and with Moderna, although an agreement has not yet been reached on New Delhi securing supplies of their vaccines. | The move was linked with an announcement from India that it is in talks with Pfizer to arrange imports of doses of the company’s Covid vaccine at the “earliest possible” opportunity. Other discussions are currently ongoing with Johnson & Johnson and with Moderna, although an agreement has not yet been reached on New Delhi securing supplies of their vaccines. |
| India currently has three vaccines in use in its inoculation program: AstraZeneca, produced domestically at the Serum Institute, Covaxin, manufactured by Indian firm Bharat Biotech, and Sputnik V, imported from Russia. | India currently has three vaccines in use in its inoculation program: AstraZeneca, produced domestically at the Serum Institute, Covaxin, manufactured by Indian firm Bharat Biotech, and Sputnik V, imported from Russia. |
| Domestic manufacturing in India has hit some serious snags in recent months, as raw supplies have run short, reducing the quantities that can be produced and in turn impacting the country’s ability to export doses as part of its involvement in the global Covax scheme. | Domestic manufacturing in India has hit some serious snags in recent months, as raw supplies have run short, reducing the quantities that can be produced and in turn impacting the country’s ability to export doses as part of its involvement in the global Covax scheme. |
| Since the start of the pandemic, India has recorded 27,369,093 confirmed cases of the virus, the second highest internationally, and 315,235 fatalities, according to data provided to the WHO as of May 27. India is still recording the highest number of new daily infections of any country, despite this figure being lower than those recorded nationally earlier in May. | Since the start of the pandemic, India has recorded 27,369,093 confirmed cases of the virus, the second highest internationally, and 315,235 fatalities, according to data provided to the WHO as of May 27. India is still recording the highest number of new daily infections of any country, despite this figure being lower than those recorded nationally earlier in May. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |